Company / Tangible Book Value per Share
CytomX Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.71
FY2025
5-year range
-$1.31 / $0.71
FY2021-FY2025
Trend
+4152.9%
vs FY2024
Sector context
#166 of 209
Health Care
What the data says
Tangible Book Value per Share changed +4153% YoY in FY2025, a notable deviation from the 9-year average annual change of -192%.
Based on SEC 10-K filings.
0.71 in FY2025.
Improved from $-0.72 to $0.71 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 209This company $0.71 Sector average $93.47
▼
-99.2% below sector average
Key checks
Key Insights
- CytomX Therapeutics, Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 4152.9% year-over-year.
- Ranks #166 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.71 | +4152.9% |
| FY2024 | -$0.02 | +97.6% |
| FY2023 | -$0.72 | +45.1% |
| FY2022 | -$1.31 | -5980.0% |
| FY2021 | -$0.02 | +88.8% |
| FY2020 | -$0.19 | -117.4% |
| FY2019 | $1.10 | -61.8% |
| FY2018 | $2.88 | +60.8% |
| FY2017 | $1.79 | -15.7% |
| FY2016 | $2.12 | +104.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026